Hongguang Nie | Infectious Diseases | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Hongguang Nie
China Medical University

Hongguang Nie
Affiliation China Medical University
Country China
Scopus ID 7103200378
Documents 69
Citations 1143
h-index 17
Subject Area Infectious Diseases
Event Health Scientists Awards
ORCID 0000-0002-9973-6354

The Innovative Research Award recognizes researchers whose scholarly contributions demonstrate sustained impact within their scientific disciplines. Hongguang Nie of China Medical University has established a notable research profile in infectious diseases through peer-reviewed publications, citation influence, and interdisciplinary collaboration. His research activities have contributed to advancing knowledge related to infectious disease mechanisms, clinical outcomes, epidemiology, and healthcare improvement initiatives. The academic record represented through indexed publications and citation metrics reflects continuing engagement with scientific inquiry and evidence-based healthcare research.[1]

Abstract

Hongguang Nie is a researcher affiliated with China Medical University whose scholarly activities are focused primarily on infectious diseases and related biomedical investigations. His publication portfolio demonstrates engagement with epidemiology, disease mechanisms, clinical research, public health applications, and healthcare outcomes. With a documented record of 69 indexed publications, 1,143 citations, and an h-index of 17, his work has achieved measurable visibility within the scientific community. The breadth of his contributions reflects sustained participation in evidence-based research, interdisciplinary collaboration, and the dissemination of findings that support improved understanding of infectious disease challenges and healthcare advancement.[1]

Keywords

Infectious Diseases, Epidemiology, Clinical Research, Public Health, Disease Prevention, Healthcare Outcomes, Biomedical Science, Medical Research, Infection Control, Translational Medicine

Introduction

Research in infectious diseases remains essential for understanding pathogen transmission, disease progression, prevention strategies, and clinical interventions. Hongguang Nie has contributed to this field through scholarly publications that support evidence-based medical knowledge and healthcare improvement. His research activities align with contemporary priorities in disease control, epidemiology, and public health advancement.[2]

Research Profile

Hongguang Nie is affiliated with China Medical University and maintains an active research profile within infectious diseases. His scholarly record includes peer-reviewed publications indexed in international databases, demonstrating ongoing participation in biomedical research. Citation performance and publication productivity indicate sustained engagement with scientific investigation and collaborative academic endeavors.[1]

Research Contributions

The research contributions of Hongguang Nie encompass infectious disease studies, clinical investigations, healthcare outcome assessments, and epidemiological analyses. His publications have supported understanding of disease-related challenges and informed evidence-based approaches in medical science. Collaborative research efforts further demonstrate his commitment to advancing knowledge through multidisciplinary scientific inquiry.[3]

Publications

The publication record associated with Hongguang Nie includes articles published in recognized scientific journals addressing infectious diseases and related healthcare topics. These works contribute to the dissemination of research findings and facilitate scholarly dialogue. Indexed publications and associated citations reflect the visibility and relevance of his research outputs within the academic community.[1]

Research Impact

Research impact can be evaluated through publication influence, citation metrics, and scholarly engagement. With more than one thousand citations and a measurable h-index, Hongguang Nie’s work demonstrates recognition within relevant research communities. His studies contribute to the broader scientific understanding of infectious diseases and support ongoing developments in healthcare research.[1]

Award Suitability

Hongguang Nie’s scholarly achievements, publication record, citation performance, and research focus in infectious diseases align with the objectives of the Innovative Research Award. His demonstrated commitment to scientific investigation and knowledge dissemination supports consideration for recognition within the Health Scientists Awards framework and related academic evaluation processes.[1]

Conclusion

Hongguang Nie has developed a credible academic profile through sustained contributions to infectious disease research. His publication output, citation record, and engagement in scientific collaboration illustrate continued involvement in advancing medical knowledge. These accomplishments support recognition within academic award programs dedicated to research excellence and healthcare innovation.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Hongguang Nie, Author ID 7103200378. Scopus. https://www.scopus.com/authid/detail.uri?authorId=7103200378
  2. Xin, S., Ding, Y., Yu, T., et al. (2025). Mesenchymal Stem Cell-Secreted KGF Ameliorates Acute Lung Injury via the Gab1/ERK/NF-κB Signaling Axis. https://pubmed.ncbi.nlm.nih.gov/40640718/
  3. Li, X., Fu, Y., Yu, T., Song, R., Nie, H., & Ding, Y. (2025). Anti-Oxidant, Anti-Inflammatory and Antiviral Properties of Luteolin Against SARS-CoV-2: Based on Network Pharmacology.     https://pubmed.ncbi.nlm.nih.gov/41011200

Yousef Moradi | Epidemiology | Best Researcher Award

Published on by Health Scientists

Assist. Prof. Dr. Yousef Moradi | Epidemiology | Best Researcher Award

Epidemiologist | Kurdistan University | Iran

Dr. Yousef Moradi is an accomplished researcher and academic whose work spans epidemiology, public health, and biomedical sciences, reflecting a sustained commitment to advancing scientific knowledge and improving population health outcomes. His expertise integrates communicable and non-communicable disease epidemiology, health inequalities, infectious disease surveillance, molecular and clinical research, and advanced evidence-synthesis methodologies. He has authored an extensive body of peer-reviewed publications and earned broad scholarly recognition through citations, editorial contributions, and active peer-review involvement with reputable international journals. Dr. Moradi’s research collaborations extend across multidisciplinary teams, national health authorities, and global agencies, contributing to policy-relevant studies, community-centered interventions, and high-impact investigations focused on vulnerable and high-risk populations. His work has informed health service delivery, strengthened public health programs, refined national guidelines, and generated actionable insights for health system improvement. He has also contributed meaningfully to academic environments through postgraduate teaching, thesis supervision, professional development activities, and curriculum enhancement, fostering a culture of scientific rigor and student achievement. His leadership in research design, data analytics, field implementation, and interdisciplinary coordination supports evidence-based decision-making and the development of informed health policies. With a strong record of contribution to global scientific discourse, a commitment to ethical and equity-driven research, and active engagement in collaborative investigations, Dr. Yousef Moradi continues to advance public health knowledge, address emerging health challenges, and promote socially responsive, evidence-informed solutions with lasting societal impact. He has 19639 citations from 233 documents with an h-index of 39.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Ghadirzadeh, B., Afshar, M., Afraie, M., Moradveisi, B., & Moradi, Y. (2025). Efficacy of zinc sulfate supplementation in managing neonatal hyperbilirubinemia: A meta-analysis. The Journal of Maternal-Fetal & Neonatal Medicine.

2. Ouyang, F., Hu, W., Reisman, J., Pogoda, T. K., Carlson, K. F., Liu, W., Moradi, Y., & colleagues. (2025). Association between PTSD and health-related social needs in US Veterans: An NLP analysis using Veterans Health Administration data. Journal of Affective Disorders.

3. Mestrovic, T., Naghavi, M., Aguilar, G. R., Weaver, N. D., Swetschinski, L. R., & colleagues. (2025). The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990–2021: A cross-country systematic analysis with forecasts to 2050. The Lancet Public Health.

4. Ghaderkhanzadeh, H., Asadi, J., Hemmati, Z., Saed, L., Nouri, E., & Moradi, Y. (2025). The role of thyroid autoimmunity in assisted reproductive techniques outcomes: An updated comprehensive meta-analysis. Clinical and Experimental Obstetrics & Gynecology.

5. Rahimi, M., Haghighi, L., Majidnia, M., Ghadirzadeh, B., & Moradi, Y. (2025). Diagnostic performance of PAPP-A and β-hCG in early detection of gestational diabetes mellitus: A meta-analysis. Acta Diabetologica.

Sulymon Saka | Infectious Diseases | Best Researcher Award

Published on by Health Scientists

Dr. Sulymon Saka | Infectious Diseases | Best Researcher Award

Resident doctor | Irrua Specialist Teaching Hospital | Nigeria

Dr. Sulýmon Ayobami Saka is an emerging Nigerian physician-scientist whose research bridges clinical medicine, audiology, infectious disease epidemiology, and the integration of artificial intelligence in healthcare. Trained at Ambrose Alli University with first-class honours equivalent in Medicine and Surgery, he has established a distinguished record of multidisciplinary research that spans global health, otolaryngology, and data-driven clinical innovation. His academic contributions include multiple peer-reviewed publications in high-impact journals such as BMC Infectious Diseases, BMC Public Health, and the Journal of Otolaryngology – Head & Neck Surgery, reflecting his commitment to evidence-based advancement in medicine. Dr. Saka’s research experience extends across several international collaborations, including the Bernhard Nocht Institute for Tropical Medicine in Germany and Sleep & Cradle® Solutions in the United States, where he contributes to studies on Lassa fever vaccine development, digital maternal and paediatric health, and long-term sequelae of infectious diseases. His scientific works emphasize the intersection of technology and clinical care—exploring how artificial intelligence, digital health platforms, and precision diagnostics can improve health outcomes in low- and middle-income settings. Recognized with multiple awards, including the ECOWAS Lassa Fever International Conference Scholarship and the Newcastle University Vice-Chancellor’s International Scholarship, Dr. Saka exemplifies a new generation of African medical researchers advancing global scientific dialogue. Through his leadership in research and mentorship, he continues to contribute to projects that not only enhance disease surveillance and clinical epidemiology but also foster equitable access to healthcare innovations. His work underscores a vision for a future where interdisciplinary science, cross-border collaboration, and artificial intelligence converge to transform patient care and strengthen health systems across the developing world. He has 9 citations from 9 documents with an h-index of 2.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Sibomana, O., Saka, S. A., Grace Uwizeyimana, M., Mwangi Kihunyu, A., Obianke, A., Oluwo Damilare, S., Bueh, L. T., Agbelemoge, B. O. G., & Omoefe Oveh, R. (2025). Artificial Intelligence–Assisted Endoscopy in Diagnosis of Gastrointestinal Tumors: A Review of Systematic Reviews and Meta-Analyses. Gastro Hep Advances.

2. Blackie, F. F., Saka, S. A., Ikhifa, C. E., Okechukwu, E. J., & Agbonifo, M. (2025). Aural Myiasis in a Retroviral-Positive Nigerian Child: A Rare Case of Extensive Ear Infestation. Research Square.

3. Emekolom, O. N., Oladipupo, E. O., Saka, S. A., Ojo, D. O., Edhugo, S. E., Olayinka, A. J., & Aremu-Cole, A. H. (2025). Compliance with Universal Standard Precautions and Perceived Influencing Factors among Nurses in a Tertiary Institution in Edo State, Nigeria. Asian Journal of Research in Nursing and Health.

4. Akhigbe, M. E., Saka, S. A., Ighodaro, O., Ghouse, M. A., Emekolom, O. N., & Okoro, O. V. (2025). Doctors’ Knowledge, Attitudes and Prescription Practices on Antibiotic Use: A Study in a Suburban Tertiary Hospital in Nigeria. BMC Health Services Research.

5. Saka, S. A., Ojo, D. O., Mezu, N. M., Uzuegbu, C. O., Ighodaro, O., Illoh, O. O., Emekolom, O. N., Akpa, O. A., Obiora, E. A., & Muogbo, A. P. (2025). Knowledge, Perception and Preventive Practices of Lassa Fever Among Mothers of Under-Five Children in an Endemic Community in Edo State, Nigeria. Research Square.

Duo Liu | Epidemiology | Best Researcher Award

Published on by Health Scientists

Prof. Duo Liu | Epidemiology | Best Researcher Award 

Deputy Director, Department of Clinical Pharmacy | Harbin Medical University | China

Professor Duo Liu, Chief Pharmacist and Doctoral Supervisor at Harbin Medical University Cancer Hospital, is a distinguished pharmaceutical scientist whose research has significantly advanced the fields of pharmacogenomics, pharmacoepidemiology, and precision oncology. With a strong background in medical genetics and pharmacology, Professor Liu has developed a research portfolio that bridges molecular pharmacology with clinical translation, focusing on the genetic mechanisms underlying cancer susceptibility, therapeutic response, and drug resistance. His pioneering contributions include transcriptome-wide association studies identifying novel genetic determinants of pancreatic and prostate cancer risk, as well as investigations into the role of NADPH oxidase polymorphisms and oxidative stress in tumor biology and treatment outcomes. Professor Liu’s scholarly work, published in leading international journals such as Cancer Research, Carcinogenesis, and International Journal of Cancer, has garnered wide recognition for its methodological rigor and clinical relevance. He has successfully led multiple national and institutional research grants, including projects supported by the National Natural Science Foundation of China, and has been honored with several prestigious distinctions for excellence in pharmaceutical sciences and young investigator achievements. As an active member of numerous professional societies, including the Chinese Pharmacological Society and the Anti-Cancer Association of China, Professor Liu contributes to shaping the evolving landscape of cancer pharmacotherapy and drug epidemiology. His collaborations with global research institutions, notably the University of Hawaii Cancer Center, underscore his commitment to advancing international scientific exchange and translational medicine. Through his leadership in clinical pharmacy and mentorship of emerging scientists, Professor Liu continues to drive innovation in personalized cancer treatment and rational drug use, promoting evidence-based healthcare practices that enhance patient outcomes and public health impact worldwide.

Profile: ORCID 

Featured Publications

1. Chen, C., Dong, Q., Wang, H., Dong, S., Wang, S., Lin, W., Jia, C., Dong, M., Jin, Y., & Liu, D. (2025, January 8). The association between NADPH oxidase (NOX) polymorphisms with immunohistochemistry and survival in diffuse large B cell lymphoma patients. Annals of Hematology.

2. Wang, S. F., Dong, S. Q., Dong, Q., Lin, W. X., Dong, M., & Liu, D. (2024). Natural product-induced oxidative stress-synergistic anti-tumor effects of chemotherapeutic agents. Traditional Medicine Research.

3. Dong, S., Chen, C., Di, C., Wang, S., Dong, Q., Lin, W., & Liu, D. (2024, December). The association between NADPH oxidase 2 (NOX2) and drug resistance in cancer. Current Cancer Drug Targets.

4. Liu, D., Bae, Y. E., Zhu, J., Zhang, Z., Sun, Y., Deng, Y., Wu, C., & Wu, L. (2023, December 15). Splicing transcriptome-wide association study to identify splicing events for pancreatic cancer risk. Carcinogenesis.

5. Liu, D., Zhao, T., Zhu, J., Sharapov, S., Tiys, E., & Wu, L. (2023, December 4). Associations between genetically predicted plasma N-glycans and pancreatic cancer risk. All Life.

Christianah Ibironke Odita | Epidemiology | Best Researcher Award

Published on by Health Scientists

Dr. Christianah Ibironke Odita | Epidemiology | Best Researcher Award 

Research Officer | National Veterinary Research Institute, Vom | Nigeria

Dr. Christianah Ibironke Odita is a distinguished Chief Veterinary Research Officer and Head of the Division of Veterinary Public Health and Preventive Medicine at the National Veterinary Research Institute (NVRI), Vom, Nigeria. She holds a Ph.D. in Veterinary Science from the University of Pretoria, South Africa, an M.Sc. in Veterinary Epidemiology and Public Health from the Royal Veterinary College, University of London, and a Master of Veterinary Public Health (MVPH) as well as a Doctor of Veterinary Medicine (DVM) from the University of Ibadan, Nigeria. Her research focuses on the epidemiology and control of infectious and zoonotic diseases, particularly at the human–animal interface, with specialization in disease surveillance, risk modeling, outbreak investigation, and preventive medicine. Dr. Odita has authored and co-authored several impactful publications in reputed journals, including Vaccine, One Health Outlook, Nigerian Veterinary Journal, and Open Veterinary Journal. Her scholarly contributions span critical studies on rabies, avian influenza, anthrax, and antimicrobial resistance in poultry, emphasizing evidence-based strategies for public health policy and disease prevention. She is a Commonwealth Scholar and a recipient of the Epix Analytics One Risk Course Awards for excellence in report writing and presentation, as well as the NVRI Research Grant Award. Dr. Odita continues to contribute to advancing veterinary epidemiology and public health through research, mentorship, and active engagement in collaborative One Health initiatives across Africa. She has 7 citations from 4 documents with an h-index of 2.

Profiles: Scopus | ORCID

Featured Publications

1. Akanbi, O. B., Alaka, O. O., Olaifa, O. S., Meseko, C. A., Inuwa, B., Ohore, O. G., Tijani, M., Jarikre, T., Ola, O., & Odita, C., et al. (2024). Pathology and molecular detection of influenza A subtype H9N2 virus in commercial poultry in Nigeria. Open Veterinary Journal.

2. Odita, C. I., Conan, A., Smith-Antony, M., Battice, J., England, S., Barry, D., Gessner, B. D., & Knobel, D. L. (2022). Non-specific effects of rabies vaccine on the incidence of self-reported common infectious disease episodes: A randomized controlled trial. Vaccine.

3. Knobel, D., Odita, C. I., Conan, A., Barry, D., Smith-Anthony, M., Battice, J., England, S., & Gessner, B. D. (2020). Non-specific effects of rabies vaccine on the incidence of common infectious disease episodes: Study protocol for a randomized controlled trial. Trials.

4. Odita, C. I., Conan, A., Barry, D., Smith-Antony, M., Battice, J., England, S., Gessner, B. D., & Knobel, D. (2020). Non-specific effects of rabies vaccine on the incidence of common infectious disease episodes: Study protocol for a randomized controlled trial.

Jack Ogony | Infectious Diseases | Outstanding Scientist Award

Published on by Health Scientists

Dr. Jack Ogony | Infectious Diseases | Outstanding Scientist Award

Research Associate | Jaramogi Oginga Odinga University | Kenya

Dr. Jack Ogony is a distinguished Research Associate at the Institute for Health Research, Epidemiological Surveillance and Trainings (IRESSEF), with over 13 years of extensive experience in public health research across Sub-Saharan Africa. He is currently completing his PhD in Epidemiology and Biostatistics at Jomo Kenyatta University of Agriculture and Technology, having previously earned a Master’s in Epidemiology from the same institution, a Postgraduate Certificate in Monitoring and Evaluation from the Kenya Institute of Management, and a BSc in Medical Laboratory Science from Masinde Muliro University of Science and Technology. Dr. Ogony’s research primarily focuses on epidemiology, infectious diseases, climate change impacts on health systems, and vaccine and drug trial studies. He has contributed significantly to understanding the burden of Plasmodium falciparum and Dengue virus infections among under five in Western Kenya and the wider implications of climate change on African healthcare infrastructure. His work has been published in high-impact journals including Frontiers in Public Health, PLOS Global Public Health, and the East African Medical Journal, others, reflecting both the depth and breadth of his contributions. He has also served as Principal Investigator on multiple USAID-funded  under the Climate Adaptation Research Program (CARP). Recognized for his leadership and expertise, Dr. Ogony is a member of several professional organizations, including the American Society of Tropical Medicine and Hygiene and the African Society for Laboratory Medicine. He has earned awards for scientific excellence and serves as a peer reviewer for multiple journals, contributing to the advancement of global health research and capacity building in and infectious disease control across Africa. He has 28 citations from 5 documents with an h-index of 2.

Profile: Scopus | ORCID

Publications

1. Ogony, J., Menya, D., Mangeni, J. N., Ayodo, G., & Karanja, S. M. (2025). Public health facility vulnerabilities, preparedness and health outcomes for P. falciparum and Dengue virus infected children under 5 years with acute febrile illnesses in Western Kenya. Frontiers in Public Health, 13, 1526558.

2. Ogony, J., Mangeni, J., Ayodo, G., Amulen, E., Scopas, F., Juma, T., … & Hannah, C. (2025). The stifling burden of climate change on African public healthcare systems. Frontiers in Public Health, 13, 1559737.

3. Ogony, J., Karanja, S., Menya, D., Mangeni, J., & Ayodo, G. (2024). Prevalence and risk factors of Plasmodium falciparum and Dengue virus infections among children below 5 years with acute febrile illnesses in Kisumu and Busia Counties. East African Medical Journal, 101(12).

4. Owusu Agyare, B., Eder, P., Shenai, S., Chendi, B. H., Carlson, C., Iradukunda, A., Mukoka, M., Ogony, J., Manigart, O., O., O., Ogbaini-Emovon, E., & Seida, A. A. (2024). Potential implications of the climate crisis on diagnostics. PLOS Global Public Health, 4(3), e0002935.

5. Ogony, J., Obiero, B., Tukhuwa, B., Gondwe, C., Kampeta, E., Orner, C., & Tiruneh, T. (2021). Research knowledge translation activities in Africa: An outlook of the opportunities and obstacles. International Journal of Scientific Advances, 2(5), 8.